Effect of Inpatient Palliative Care on Quality of Life 2 Weeks After Hematopoietic Stem Cell Transplantation
Author(s) -
Areej ElJawahri,
Thomas W. LeBlanc,
Harry VanDusen,
Lara Traeger,
Joseph A. Greer,
William F. Pirl,
Vicki A. Jackson,
Jason Telles,
Alison M. Rhodes,
Thomas R. Spitzer,
Steven L. McAfee,
Yi-Bin A. Chen,
Stephanie S. Lee,
Jennifer S. Temel
Publication year - 2016
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2016.16786
Subject(s) - medicine , quality of life (healthcare) , palliative care , transplantation , mood , hematopoietic stem cell transplantation , randomized controlled trial , intervention (counseling) , physical therapy , clinical trial , psychiatry , nursing
During hospitalization for hematopoietic stem cell transplantation (HCT), patients receive high-dose chemotherapy before transplantation and experience significant physical and psychological symptoms and poor quality of life (QOL).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom